These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2864741)

  • 21. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
    Prouse PJ; Shawe D; Gumpel JM
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1407. PubMed ID: 2879599
    [No Abstract]   [Full Text] [Related]  

  • 23. The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.
    Farr M; Tunn E; Crockson AP; Bacon PA
    Clin Rheumatol; 1984 Dec; 3(4):473-81. PubMed ID: 6151882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1987 May; 46(5):398-402. PubMed ID: 2884932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid arthritis: is serum vitamin B12 high in active disease?
    Grindulis KA; Calverley M; Cox C
    J Rheumatol; 1984 Apr; 11(2):211-2. PubMed ID: 6144796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis.
    Taggart AJ; Hill J; Astbury C; Dixon JS; Bird HA; Wright V
    Br J Rheumatol; 1987 Feb; 26(1):32-6. PubMed ID: 2880632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease.
    Laasila K; Leirisalo-Repo M
    Scand J Rheumatol; 1994; 23(6):338-40. PubMed ID: 7801059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
    Haagsma CJ; Blom HJ; van Riel PL; van't Hof MA; Giesendorf BA; van Oppenraaij-Emmerzaal D; van de Putte LB
    Ann Rheum Dis; 1999 Feb; 58(2):79-84. PubMed ID: 10343521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Megaloblastic anaemia due to sulphasalazine responding to drug withdrawal alone.
    Grieco A; Caputo S; Bertoli A; Caradonna P; Greco AV
    Postgrad Med J; 1986 Apr; 62(726):307-8. PubMed ID: 2872667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toleration, side-effects and efficacy of sulphasalazine in rheumatoid arthritis patients of different ages.
    Wilkieson CA; Madhok R; Hunter JA; Capell HA
    Q J Med; 1993 Aug; 86(8):501-5. PubMed ID: 8105504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
    Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.
    Boyd O; Gibbs AR; Smith AP
    Br J Rheumatol; 1990 Jun; 29(3):222-4. PubMed ID: 1972634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.